Reverse triiodothyronine (rT3) is metabolized predominantly by outer ring deiodination to 3,3'-diiodothyronine (3,3'-T2) in the liver. Metabolism of rT3 and 3,3'-T2 by isolated rat hepatocytes was analyzed by Sephadex LH-20 chromatography, high performance liquid chromatography, and radioimmunoassay, with closely agreeing results. Deiodinase activity was inhibited with propylthiouracil (PTU) and sulfotransferase activity by sulfate depletion or addition of salicylamide or dichloronitrophenol. Normally, little 3,3'-T2 production from rT3 was observed, and 1251 was the main product of both 3,13'-'25iT2 and 13',5'-25IlrT3. PTU inhibited rT3 metabolism but did not affect 3,3'-T2 clearance as explained by accumulation of 3,3'-T2 sulfate. Inhibition of sulfation did not affect rT3 clearance but 3,3'-T2 metabolism was greatly diminished. The decrease in I formation from rT3 was compensated by an increased recovery of 3,3'-T2 up to 70% of rT3 metabolized. In conclusion, significant production of 3,3'-T2 from rT3 by rat hepatocytes is only observed if further sulfation is inhibited.
Introduction
In euthyroid subjects the main secretory product of the thyroid is thyroxine (T4).' Some 3,3',5-triiodothyronine (T3) is secreted as well, but thyroidal production of 3,3',5'-triiodothyronine (rT3) is negligible. More than 97.5% of plasma rT3 and -80% of plasma T3 originate from peripheral deiodination of T4 (1) . As thyroid hormone bioactivity is exerted largely through T3, it is important to understand the regulatory mechanisms of iodothyronine metabolism.
In rats, three types of iodothyronine-deiodinating enzymes have been identified (2) . Most likely, the type I deiodinase of liver catalyzes both inner ring deiodination (IRD) and outer ring deiodination (ORD) of iodothyronines (2) . A similar enzyme is present in kidney and thyroid (2) . Type II deiodinase has been localized in brain, pituitary, brown adipose tissue, and placenta.
It deiodinates only the outer ring of substrates such as T4 and rT3 (2) (3) (4) . Type III enzyme is found in brain, placenta, and skin, and it is a specific inner ring deiodinase (2, 5) . Type I deiodinase is inhibited by 6-propylthiouracil (PTU), while types II and III are PTU insensitive (2) . Thus, there may be two sources of plasma rT3, namely type I or type III IRD of T4. There are also two pathways of rT3 deiodination, i.e., type I and type II ORD to 3,3'-diiodothyronine (3,3'-T2) .
Considering the high rate ofrT3 ORD by the type I deiodinase (2) , it is likely that little rT3 produced from T4 in the liver is released into the circulation. It would seem, therefore, that most plasma rT3 is derived from type III deiodination of T4, while it is cleared mainly by the liver. This hypothesis is substantiated by measurements of arterio-venous gradients of rT3 across the liver in patients with mild liver failure. 2 In vivo studies in normal rats have demonstrated that the type I deiodinase is the predominant site for the peripheral production of T3 (6) . Opposite variation in plasma T3 and rT3 concentrations has been observed in a number ofclinical situations, in which changes are due to a decrease in both the production of plasma T3 and the clearance of plasma rT3 (7) . To investigate the potential importance ofchanges in type I deiodinase activity for the regulation of thyroid hormone metabolism, we initiated studies of the deiodination of rT3 by isolated rat hepatocytes.
Initial results, using outer ring 1251-labeled rT3, showed that radioiodide was the main product, but little production of 3,3'-T2 from unlabeled rT3 could be detected by radioimmunoassay (RIA) (8) . Further investigations have demonstrated rapid metabolism of added 3,3'-T2 in rat hepatocytes by s'ulfation and subsequent ORD of the 3,3'-T2 sulfate (3,3'-T2S) formed (9) . 3,3'-T2S is a far better substrate for the type I deiodinase than 3,3'-T2 itself (9) . This may be the reason for our failure to detect significant production of 3,3'-T2 from rT3 by liver cells. If so, the yield of 3,3'-T2 produced by this pathway should increase if its further sulfation is inhibited. This hypothesis was tested in the present study using rat hepatocytes with diminished phenol sulfotransferase activity.
Methods
The materials used are essentially the same as described previously (10) .
Carrier-free 3,[3'-'251]T2 and [3',5'-'25IJrT3 were prepared in our laboratory by radioiodination of 3-iodothyronine or of 3,3'-T2 (Henning GmbH, Berlin, Federal Republic of Germany) using the chloramine T method (1 1, 12) and purified by Sephadex LH-20 chromatography. Salicylamide (SAM) and 2,6-dichloro-4-nitrophenol (DCNP) were purchased from Riedel-de Haen AG, Hannover, Federal Republic ofGermany. All other chemicals were of the highest quality commercially available.
Hepatocytes. Rat hepatocytes were prepared by collagenase perfusion (10) Sulfate depletion. 'Hepatocytes were preincubated for 30 min at 370C in Dulbecco's'solution which contained 1 mM MgCl2, 2 mM glutamine, and 1 mM vitamin C with or without 100 MM SAM. Incubations were done as described above in medium without SQ42-. Controls were preincubated and incubated in medium containing MgSO4.
Analysis of incubation medium. Incubation media with unlabeled rT3 and 3,3'-T2 were analyzed before and after hydrolysis with specific RIAs (1 1, 12) . Hydrolysis of eventual S conjugates was achieved by addition of 250 Ml 1 N HCI to I00-Ml samples and treatment for 1 h at 80'C (13) . Thereafter, 300 Ml 1 N NaOH was added. The nonhydrolyzed samples were treated the same way but without heating. RIA was done in duplicate on 50-Ml aliquots of the mixtures.
Incubation media with labeled rT3 and 3,3'-T2 were assayed by column chromatography. An equal volume of 1 N HCI was added to 500-Ml samples and the mixtures were applied to small (bed volume 0.75 ml) Sephadex LH-20 columns equilibrated in 0.1 N HC. Stepwise elution was done by successive application of 2 X 1 ml 0.1 N HCl, 6 X 1 ml H20, 6 X 1 ml 0.1 N NaOH-ethanol (9:1, vol/vol), and 3 X I ml 0.1 N NaOH-ethanol (1:1, vol/vol).
High performance liquid chromatography (HPLC). Analysis of rT3 and 3,3'-T2 conjugates and native iodothyronines was accomplished by reverse-phase HPLC. For this we used a 10 X 0.3-cm CP Spher C18 column (Chrompack, Middelburg, The Netherlands), a model 6000 A solvent delivery system and a model 440 fixed wavelength detector (Waters Assoc., Millipore Corp., Milford, MA). Flow was 0.6 ml/min and absorbance was measured at 254 nm. For separation of conjugates a 20:80 vol/vol mixture of acetonitrile and 0.02 M ammonium acetate (pH 4) was used, and for separation of rT3 and 3,3'-T2 a 55:45 vol/vol mixture of methanol and 0.02 M ammonium acetate (pH 4) was employed.
To obtain the conjugates for HPLC analysis, the water fractions of the LH-20 chromatography were pooled, acidified, and rechromatographed. The columns were washed with 2 ml 0.1 N HC1, 0.5 ml H20, and 0.5 ml 0.1 M ammonia in ethanol. Conjugates were then collected in a subsequent fraction of I ml 0.1 M ammonia in ethanol. The solvent was evaporated at 50'C under a stream of N2. To obtain the iodothyronine fraction, medium was processed as above and LH-20 chromatography was modified as follows. After the H20 fractions, columns were washed with 0.5 ml 0.1 M ammonia-ethanol (1:1 vol/vol), and iodothyronines were collected in 1 ml 0.1 M'ammonia in ethanol. The solvent was evaporated as above.
Enzymatic analysis of rT3 and 3,3-T2 conjugates. Another method by which the'conjugates were identified was by enzymatic hydrolysis with glucuronidase and sulfatase in the presence or absence of saccharic acid lactone (10) . Hydrolysis was quantified by LH-20 chromatography and the liberated iodothyronines were identified by HPLC.
Analysis of cell content. Cell-associated radioactivity was extracted after removing the medium by immediate addition of I ml 0.1 N NaOH. After centrifugation, 0.5 ml of supernatant was chromatographed on LH-20 as described above for medium.
Miscellaneous. The influence of SAM (10-1000MuM) (14) in 0.1 M phosphate buffer (pH 7.2), 2 mM EDTA, and 5 mM dithiothreitol (DTT). The free fractions of rT3 and 3,3Y-T2 in incubation medium were determined by equilibrium dialysis. Cellular ATP content was measured according to the method described by Jaworek et al. (15) . Data analysis. In each experiment, I-production was corrected for the amount of I-recovered from control incubations, while the 3,3'-T2 production from rT3 was corrected for the slight contamination of the 3,3'-T2 fraction with rT3. Production of unlabeled 3,3'-T2 was corrected for rT3 crossreactivity (0.03%) in the 3,3'-T2 RIA. Statistical analysis was done by Student's t test for unpaired data.
Results
Sephadex LH-20 chromatography. The Sephadex LH-20 chromatographic pattern of I-, 3,3'-T2S, 3,3'-T2, and rT3 is depicted in Fig. 1 . More than 97% of 125I-activity was found in fractions [1] [2] [3] [4] Time dependence of3,3-T2 and rT3 metabolism. was the main metabolite, the amount of which was inversely correlated with that of remaining 3,3'-T2. The semi-logarithmic plot of the latter against time demonstrated that the disappearance of 3,3'-T2 followed first order kinetics with a rate constant of0.031 min'. Additipn ofSAM strongly inhibited I-formation.
In the presence of this inhibitor 3,3'-T2 clearance remained a first order process with a rate constant of 0.007 min-'. In rT3 incubations I-was also the main metabolite found, while 3,3'-T2 formation was undetectable under control conditions. Addition of SAM resulted in the inhibition of I-release with a reciprocal accumulation of 3,3'-T2. Clearance of rT3 was also a first order process, characterized by a rate constant of 0.014 min', which was not influenced by SAM. The identity of the 3,3'-T2 produced was further tested by HPLC analysis ( . Addition of PTU also led to an increase in cell-associated radioactivity, from < 5% in the absence to 22% in the presence of the inhibitor. This radioactivity was predominantly in the form of conjugates and presumably represented the accumulation of 3,3'-T2S within the cells. Addition of 10-1,000 AM SAM resulted in a progressive decrease in the clearance of 3,3'-T2 independent of PTU. This was indicated by the parallel decrease of I-formation without PTU and of 3,3'-T2S accumulation with PTU.
With the SAM-induced inhibition of 3,3'-T2 clearance there was an increase in cell-associated 3,3'-T2, irrespective of PTU. In contrast to 3,3'-T2, rT3 metabolism was almost completely blocked by PTU but was not affected by even 1,000 MM SAM. In the absence of SAM, little 3,3'-T2 production was observed in the medium once again, and no 3,3'-T2 was detectable in the cells. With increasing SAM concentrations, 3,3'-T2 accumulation in the medium was accompanied by a rise in cellular radioactivity from 5 to 12%, part of which was in the form of 3,3'-T2. Based on the dose-effect relationship for SAM on the metabolism of both 3,3'-T2 and rT3, 100 AM was chosen as the near-maximal sulfotransferase inhibitory concentration.
3,3'-T2 and rT3 metabolism; correlation between LH-20 and RIA. in medium was measured by RIA, inhibition of the clearance of 3,3'-T2 by these treatments was 52, 62, and 1%, respectively. After incubation for 60 min with [125I]rT3, 48% of radioactivity in the medium was accounted for by 1251-, while the sum of the conjugate and 3,3'-T2 fractions was only 2%. Again, rT3 disappearance was not changed by SAM, but I-formation was decreased by 13.2% (-2.6 nM I-) while 3,3'-T2 accumulation was increased by 13.9% (-2.8 nM 3,3'-T2). These results correspond with an increase of immunoassayable 3,3'-T2 by 23.0% (-2.3 nM 3,3'-T2 ). On the basis of the results obtained by LH-20 chromatography and by RIA, it was calculated that with SAM 51 and 54%, respectively, ofthe amount ofrT3 cleared was recovered as medium 3,3'-T2. Similar results were obtained with DCNP, except that the acceleration ofrT3 metabolism seen with this inhibitor was different. PTU inhibited rT3 disappearance from the medium by 77 and 67% as estimated by LH-20 and RIA, respectively. S dependence of 3,3'-T2 and rT3 metabolism. As discussed above, 3,3'-T2 was metabolized predominantly by successive sulfation and ORD. The small amount ofconjugates found after incubation of 3,3'-T2 in S-containing medium (Fig. 5) was shown by HPLC to consist of similar proportions of 3,3'-T2 glucuronide (3,3'-T2G) and 3,3'-T2S (Fig. 6 ). In the presence of PTU, I-formation was again strongly suppressed (Fig. 5) , while radioactivity in the conjugate fraction almost entirely eluted in the position of 3,3'-T2S with no change in the absolute amount of 3,3'-T2G recovered (Fig. 6 ). If cells were preincubated with S-free medium and incubated with 3,3'-T2 in this medium plus PTU, conjugation and clearance were diminished by 55%. A further reduction in 3,3'-T2 conjugation to 30% was observed if SAM was added to the preincubation, while the experiment was otherwise conducted under the same S-free conditions (Fig. 5) . HPLC analysis of the conjugate fraction demonstrated that 3,3'-T2S formation was virtually blocked, and that now most radioactivity eluted in the position of 3,3'-T2G (Fig. 6 ). In the absence of PTU, I-release was decreased from 74 to 38% by omission of S from the medium, and further to 17% after addition of SAM to the preincubation. However, conjugates represented an increasing proportion of the radioactivity in the medium, i.e., 7, 10, and 15%, respectively (Fig. 5) . HPLC revealed that this increase was totally accounted for by a rise in 3,3'-T2G (Fig. 6) .
Clearance of rT3 was not S dependent. Iodide production, however, decreased from 48% in the presence of S to 38% in the absence of S, and further to 33% after preincubation with SAM.
The loss of I-was completely compensated for by the accumulation of 3,3'-T2, which amounted to 1, 9, and 14% under these conditions, respectively (Fig. 5) . In S-supplemented incubations the conjugate fraction contained small amounts of rT3G, 3,3'-T2G, and 3,3'-T2S. S depletion induced an increase in conjugates mostly in the form of 3,3'-T2G, although even after preincubation with SAM the conjugate fraction comprised only 5% of medium radioactivity. Inhibition of deiodination by PTU augmented the appearance of conjugates in S-replete incubations (Table I, Fig. 6 ). In S-deplete cultures, addition of PTU led to a decrease in T2G and an increase in rT3G without a change in the total amount of conjugate formed (Fig. 6 ).
Effect ofsubstrate concentration on rT3 metabolism (Fig. 7) .
In S Effects ofSAM and DCNP on free substrate levels, cellular integrity, and deiodinase activity (Table II) . In the absence of inhibitors, the free fraction of 3,3'-T2 and rT3 in Dulbecco's medium containing 0.1% BSA was 8.5 and 4.9%, respectively. Up to 1,000 MM, SAM did not influence the free 3,3'-T2 and rT3 fractions. DCNP had no effect on free 3,3'-T2, while there was a dose-dependent increase in free rT3 up to 7.8% at 100 uM DCNP.
Up to 100 MM, SAM did not inhibit rT3 deiodination by rat liver microsomes, but a 25% reduction of I-release was observed at 1,000 uM SAM. In contrast, 100 uM DCNP resulted in a 65% lowering of deiodinase activity, while only slight inhibition was noted at 10 MM. 18). These workers also provided evidence for the conversion of both T3 and rT3 to 3,3'-T2 in vivo by demonstration of the presence of radioactive 3,3'-T2 in the kidney after administration of labeled T3 or rT3 to thyroidectomized rats (19) . In humans, most plasma 3,3'-T2 originates from IRD of T3 (20, 21) . Plasma 3,3'-T22 (22) and rT32 are cleared predominantly by the liver, which indicates that they are derived from extrahepatic IRD of T3 and T4, respectively. It is likely that these processes are catalyzed by the type III deiodinase, which specifically acts on the inner ring of iodothyronines and which has been localized in tissues such as brain and skin but not in liver (2, 5) . In our studies we focused on the role of the type I deiodinase in the hepatic clearance of rT3.
Numerous studies have appeared on the characteristics of the deiodination of different iodothyronines by homogenates and subcellular fractions of rat liver (for a review, see reference 2). These studies have established the existence of a so-called type I deiodinase in the endoplasmic reticulum, which is an integral membrane protein and requires thiols for deiodinase activity. The enzyme is a nonspecific deiodinase that is capable ofremoving iodines from either ring ofiodothyronine substrates (2) . However, the enzyme is most effective in the ORD of rT3 (2, 23 tocytes. In spite ofthe high rate ofrT3 to 3,3'-T2 conversion with isolated microsomes, and the stability of the product in such incubations (23) , surprisingly little production of 3,3'-T2 from rT3 was observed in incubations with intact liver cells (8) . That nevertheless rapid ORD took place in this system was demonstrated by the large amounts of radioiodide released from outer ring labeled rT3 (8) . This implies that any 3,3'-T2 formed would have undergone further deiodination, as substantiated by analysis of the metabolism of added 3,3'-T2. Similar rapid degradation ofboth rT3 and 3,3'-T2 with extensive I-formation was observed by Flock et al. (24) in isolated rat liver perfusions. The unexpected rapid deiodination of 3,3'-T2 in rat liver cells in contrast to microsomes was subsequently shown to be due to the efficient sulfation of 3,3'-T2 in hepatocytes yielding 3,3'-T2S, a highly effective substrate for the type I deiodinase (10). A similar facilatory effect of S conjugation has been described for the IRD of T3 and T4 (25, 26) .
In the present study, we tested the hypothesis that it is possible to demonstrate production of 3,3'-T2 from rT3 in this system if further metabolism, especially sulfation, of 3,3'-T2 is prevented. In experiments with isolated rat hepatocytes three methods are available in principle to manipulate the sulfotransferase activity ofthe cells. Firstly, it has been demonstrated that there is a rapid equilibrium between medium and cellular inorganic S levels (27) (28) (29) . Rat liver cells also have the capacity to generate S by oxidation of the sulfur-containing amino acids methionine and cysteine (28) . Therefore, considerable S depletion is obtained by keeping cells in medium without S and possible precursors. Secondly, sulfation of phenolic substances may be prevented by competitive substrates (30) . SAM has been shown to undergo extensive sulfation and at higher concentrations also glucuronidation in rat liver cells. For instance, Koike et al. (29) have reported that in isolated rat hepatocytes, sulfation of SAM is characterized by an apparent K. value of 6 MM with a Vm,, value of 2 nmol/min per 106 cells at 1.2 mM inorganic S in the medium. This level of S is similar to that used in our system (1 mM), providing near-maximal rates of S conjugation (9, 10 Time-course studies of the metabolism of 3,3'-T2 and rT3 demonstrated that under the conditions used, i.e., 10-nM substrate levels and S-supplemented cells, clearance of both substances follows first-order rate kinetics (Fig. 2) . Such kinetics were also observed in the presence of 100 MM SAM, which did not affect the rate constant for rT3 but lowered that for 3,3'-T2 by 77% . These results show that conjugation is an important, rate-limiting step in the metabolism of 3,3'-T2, but not of rT3. SAM does not only inhibit degradation of added 3,3'-T2, but apparently also that of 3,3'-T2 produced from rT3. No evidence was obtained by HPLC for the generation of iodothyronines other than 3,3'-T2 such as 3',5'-T2 or 3'-iodothyronine (Fig. 3) . (Table II) further underscores the usefulness of this compound in studies of the conjugation of thyroid hormone. Table I illustrates that similar effects on the metabolism of 3,3'-T2 and rT3 are obtained with 100 MAM DCNP as with 100 MM SAM. However, DCNP also exhibits some unwanted side effects. DCNP has been shown by Mulder and co-workers to be a specific inhibitor ofsulfation in vivo as well as in vitro without being sulfated itself (31, 32) . This compound does not affect glucuronidation and was reported to have no major toxic effects, which is in contrast with our findings that show a substantial decrease in cellular ATP by 100 MAM DCNP. This effect on ATP may be related to the toxic effects on oxidative phosphorylation generally observed with phenols (33, 34) which may be promoted by the relative deficiency of nutrients and oxygen in our system. A further disadvantage ofDCNP is that it may inhibit deiodinase activity directly, as demonstrated by the influence of DCNP in incubations with microsomes (Table II) . Similar to SAM, however, intracellular DCNP concentrations may be substantially lower than the total concentrations added to the medium. One possible reason for this is that DCNP binds extensively to BSA (31) . The decreased availability of DCNP to the cells, therefore, prevents direct inhibition of the deiodinase, and metabolism of rT3 is even stimulated by 100 MM DCNP. This latter phenomenon is probably due to displacement of rT3 from BSA (Table  II) , which causes a shift ofrT3 into the intracellular compartment.
Nevertheless, results obtained with DCNP are in confirmation ofthe experiments with SAM which underscore the importance of sulfation for the metabolism of 3,3'-T2 but not of rT3.
The Sephadex LH-20 method used in this study does not permit the distinction of the different conjugates of 3,3'-T2 and rT3. Previous findings have indicated that sulfate conjugates do not crossreact in RIAs of non-conjugated iodothyronines (13) . The RIA data presented in Table I S-deplete hepatocytes were prepared by preincubation with medium lacking inorganic S and by using the same medium for incubation with substrate. The results obtained with 3,3'-T2 in the presence of PTU showed that under these conditions S depletion was not complete, and led to some residual 3,3'-T2S formation. Further exhaustion of cellular S stores was obtained by preincubation with SAM. A similar approach has been followed by other investigators to reveal the significance ofthe conjugation reactions in the elimination of drugs (35, 36) . Thus, substantial lowering of hepatic UDP-glucuronic acid and adenosine 3'-phosphate 5'-phosphosulfate levels has been achieved by in vivo treatment with SAM due to the consumption ofthese co-factors in the glucuronidation and sulfation of the drug (35, 36) . Application of a SAM load induces a prolonged lowering of body S stores with pronounced decrements in plasma S levels (35) , but depletion of tissue UDP-glucuronic acid is only transient, and co-factor levels are rapidly restored (36) . We also obtained evidence for the reversible nature of these effects. After preincubation with SAM, 3,3'-T2 sulfation rates after readdition of S042-and T3 glucuronidation rates (Eelkman Rooda, S. J., and T. J. Visser, unpublished observations) were completely normal.
In S-replete cells, sulfation is by far the predominant pathway of 3,3'-T2 metabolism, although little 3,3'-T2S is recovered in the absence of PTU due to further deiodination. However, in S-deplete cells the contribution of the glucuronidation pathway increases, and results in augmented accumulation of 3,3'-T2G from added 3,3'-T2, as well as from added rT3. The latter findings indicate that glucuronidation does not facilitate deiodination of 3,3'-T2, which is in contrast to the stimulatory effects ofsulfation. Although ORD is the foremost step in the hepatic metabolism of rT3, some glucuronidation of this metabolite is observed, especially in the presence of PTU. The low rate of rT3 sulfation in comparison with the highly efficient sulfation of 3,3'-T2 is in agreement with data of the structure-activity relationship for the sulfation of iodothyronines by isolated phenol sulfotransferases (37) .
The effects of substrate concentration on the conversion of rT3 to 3,3'-T2 by rat liver cells indicate that half-maximal 3,3'-T2 production is obtained between 10 and 100 nM rT3. This is in the same concentration range as the Km value determined for rT3 ORD in reactions with microsomes and DTT (23) . However, the rT3 levels in the culture medium are largely protein bound and certainly do not reflect intracellularly available substrate concentrations. Together with the uncertainty about the saturation kinetics ofthe type I deiodinase in its natural environment it is, therefore, impossible to interpret these findings in terms of a possible uphill gradient of rT3 across the cell membrane (38) .
In conclusion, our results demonstrate that in isolated rat hepatocytes, rT3 is metabolized almost exclusively by ORD. However, the immediate product of this reaction, 3,3'-T2, is not observed unless its further metabolism by successive sulfation and deiodination is inhibited. Evidence for formation of 3',5'-T2 in these studies was not obtained. In different clinical situations, plasma T3 and rT3 levels change in opposite directions due to parallel alterations in the rate of T3 production and rT3 degradation. This is understandable, as both processes concern ORD reactions mediated by common enzymes among which the type I deiodinase of the liver plays an important function. It is expected, therefore, that a detailed knowledge of the ORD
